Northern Trust
JSPR icon

Northern Trust’s Jasper Therapeutics JSPR Stock Holding History

Northern Trust’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Buy
1,396
+243
+21% +$5.46K ﹤0.01% 4380
2026
Q1 		$30.3K Hold
1,153
– – ﹤0.01% 4302
2025
Q4 		$63.3K Buy
1,153
+23
+2% +$1.38K ﹤0.01% 4231
2025
Q3 		$80.7K Sell
1,130
-34
-3% -$3.09K ﹤0.01% 4185
2025
Q2 		$194K Sell
1,164
-2,272
-66% -$336K ﹤0.01% 3945
2025
Q1 		$443K Sell
3,436
-43
-1% -$8.58K ﹤0.01% 3624
2024
Q4 		$2.23M Sell
3,479
-86
-2% -$53.7K ﹤0.01% 2961
2024
Q3 		$2.01M Buy
3,565
+2,588
+265% +$1.55M ﹤0.01% 3002
2024
Q2 		$665K Buy
977
+220
+29% +$158K ﹤0.01% 3400
2024
Q1 		$666K Buy
757
+241
+47% +$128K ﹤0.01% 3469
2023
Q4 		$122K Hold
516
– – ﹤0.01% 4060
2023
Q3 		$108K Hold
516
– – ﹤0.01% 3992
2023
Q2 		$212K Sell
516
-2
-0.4% -$891 ﹤0.01% 3806
2023
Q1 		$281K Buy
518
+446
+619% +$247K ﹤0.01% 3700
2022
Q4 		$10.4K Hold
72
– – ﹤0.01% 4569
2022
Q3 		$17K Hold
72
– – ﹤0.01% 4572
2022
Q2 		$41K Buy
72
+4
+6% +$3.42K ﹤0.01% 4460
2022
Q1 		$72K Hold
68
– – ﹤0.01% 4441
2021
Q4 		$159K Buy
+68
New +$191K ﹤0.01% 4278

Other funds holding JSPR

Velan Capital Investment Management
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Rock Springs Capital Management
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Northern Trust's JSPR Position: Q2 2026 in Review

Northern Trust increased its Jasper Therapeutics (JSPR) stake by 21% in Q2 2026, buying an estimated $5.46K and bringing the position to 1,396 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4380.

Northern Trust first reported a position in JSPR in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.23M in Q4 2024. 43 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Northern Trust held 1,396 shares of Jasper Therapeutics worth $17.6K as of Q2 2026.
  • Northern Trust bought 243 Jasper Therapeutics shares in Q2 2026, an estimated $5.46K.
  • Jasper Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4380 holding.
  • Northern Trust first reported a position in Jasper Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Northern Trust's Jasper Therapeutics position peaked at $2.23M in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.